A phase I study to assess the safety, tolerability, and PK of dovitinib (D) in combination with gemcitabine (G) and capecitabine (C) in patients with advanced solid tumors.
Gerald J. Fetterly
No relevant relationships to disclose
Laura Pitzonka
No relevant relationships to disclose
Yujie Zhao
No relevant relationships to disclose
Grace K. Dy
No relevant relationships to disclose
Renuka V. Iyer
No relevant relationships to disclose
Susan Taubes
No relevant relationships to disclose
Jose Ricardo Perez
No relevant relationships to disclose
Kenneth W. Culver
No relevant relationships to disclose
John Wilton
No relevant relationships to disclose
Krystin Mongiardo
No relevant relationships to disclose
Wei Tan
No relevant relationships to disclose
William E. Brady
No relevant relationships to disclose
Amy Whitworth
No relevant relationships to disclose
Alex A. Adjei
No relevant relationships to disclose
Wen Wee Ma
No relevant relationships to disclose